Skandinaviska Enskilda Banken (SEB)’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-43,245	Closed	-$605K	–	815
2025 Q2	$605K	Hold	43,245	–	–	﹤0.01%	690
2025 Q1	$588K	Hold	43,245	–	–	﹤0.01%	677
2024 Q4	$875K	Hold	43,245	–	–	﹤0.01%	668
2024 Q3	$1.26M	Hold	43,245	–	–	0.01%	651
2024 Q2	$1M	Hold	43,245	–	–	﹤0.01%	642
2024 Q1	$887K	Sell	43,245 -304,958	-88%	-$5.73M	﹤0.01%	669
2023 Q4	$7.47M	Hold	348,203	–	–	0.04%	314
2023 Q3	$7.18M	Hold	348,203	–	–	0.05%	308
2023 Q2	$10.3M	Buy	348,203 +41,233	+13%	+$1.16M	0.07%	258
2023 Q1	$7.07M	Sell	306,970 -2,122	-0.7%	-$58.4K	0.05%	320
2022 Q4	$8.6M	Buy	309,092 +17,784	+6%	+$529K	0.06%	273
2022 Q3	$8.94M	Buy	291,308 +78,485	+37%	+$2.55M	0.07%	257
2022 Q2	$6.26M	Buy	212,823 +74,324	+54%	+$1.95M	0.05%	320
2022 Q1	$4.46M	Sell	138,499 -64	-0%	-$2.2K	0.03%	431
2021 Q4	$6.24M	Buy	138,563 +6,509	+5%	+$308K	0.03%	375
2021 Q3	$6.66M	Buy	132,054 +102,269	+343%	+$5.76M	0.04%	358
2021 Q2	$2.34M	Buy	29,785 +3,685	+14%	+$228K	0.01%	621
2021 Q1	$1.49M	Hold	26,100	–	–	0.01%	739
2020 Q4	$2.19M	Buy	+26,100	New	+$1.58M	0.02%	618